Medical writers operate at the intersection of science and communication, translating dense clinical data into clear, precise, and compliant documents. Whether you are drafting a clinical study report, a manuscript for peer review, or patient education materials, AI prompts can help you structure your thinking, overcome writer's block, and accelerate your first drafts. These 35 prompts cover the full breadth of the medical writing profession.
1. Clinical Study Reports and Synopses
Write a structured synopsis for a Phase III randomized controlled trial comparing [Drug A] vs. placebo in patients with moderate-to-severe rheumatoid arthritis. The primary endpoint was ACR20 response at Week 24. Include sections for objective, design, population, endpoints, and key results placeholder.
Draft the Introduction section for a Clinical Study Report (CSR) for a cardiovascular outcomes trial. The investigational drug is an SGLT2 inhibitor. The introduction should summarize the disease burden, unmet need, mechanism of action, and rationale for the trial. Approximately 400 words.
I need to write the Safety Summary section of a CSR. The trial had 850 participants per arm and ran for 52 weeks. Common adverse events included nausea (12% vs. 8%), headache (9% vs. 10%), and one case of anaphylaxis in the treatment arm. Draft this section following ICH E3 guidelines.
Write a plain-language version of the following efficacy results table from a clinical trial: [paste table]. The audience is a non-scientific regulatory affairs team member. Explain what the primary and secondary endpoints mean and whether the trial met its objectives.
Generate a list of 10 consistency checks I should perform before submitting a Clinical Study Report to ensure alignment between the protocol, statistical analysis plan, and the CSR body text.
2. Regulatory Documents
Draft the Proposed Indication and Mechanism of Action section for a New Drug Application (NDA) briefing document. The drug is a novel oral JAK1 inhibitor for moderate-to-severe atopic dermatitis. Follow the expected FDA format and tone.
Write a benefit-risk summary for a biologics license application for a monoclonal antibody targeting IL-17A for plaque psoriasis. Highlight the efficacy evidence, key safety signals, and the unmet medical need that justifies approval. Approximately 500 words.
I need to write responses to FDA information requests (IR) for our NDA. The FDA is asking us to clarify the patient population used for the primary efficacy analysis. Draft a clear, concise response that references the relevant sections of the SAP and CSR.
Create an outline for a European Public Assessment Report (EPAR) product information update following the approval of a new pediatric indication for an existing oncology drug. Flag where new clinical data sections need to be inserted.
Draft a Risk Management Plan (RMP) summary for a new anticoagulant. Include sections for important identified risks (major bleeding), important potential risks (drug interactions), and proposed risk minimization measures.
3. Manuscripts and Publications
Write a structured abstract for a manuscript reporting the results of a systematic review and meta-analysis on the efficacy of GLP-1 receptor agonists for weight management in adults with type 2 diabetes. Include background, methods, results, and conclusions sections.
I am drafting the Discussion section of a clinical trial manuscript. The trial showed a statistically significant but modest treatment effect (OR 1.4, 95% CI 1.1–1.8). Help me frame the clinical meaningfulness of this result, acknowledge limitations, and position the findings within existing literature.
Review the following Methods section of a randomized trial manuscript for completeness against the CONSORT 2010 checklist: [paste Methods text]. Identify any missing or incomplete items and suggest specific additions.
Write a cover letter to the editor for a manuscript submission to the New England Journal of Medicine. The manuscript reports Phase III results of a novel treatment for non-small cell lung cancer that showed a significant improvement in overall survival.
Suggest five high-impact journals appropriate for submitting a retrospective cohort study on hospital readmission rates in heart failure patients. For each journal, note the typical turnaround time, impact factor range, and any specific formatting requirements.
4. Patient and Lay Summaries
Write a plain-language summary of the following clinical trial results for patients with Crohn's disease: [paste results]. The summary should be written at a sixth-grade reading level, avoid medical jargon, and explain what the results mean for patients considering this treatment.
Create a one-page patient information leaflet for a new biologic injection for moderate-to-severe psoriasis. Cover: what the drug is, how to inject it, what side effects to watch for, and when to call a doctor. Use simple language and a friendly, reassuring tone.
Write a lay summary of a Phase II study on a new treatment for Alzheimer's disease for inclusion in a clinical trial registry (e.g., ClinicalTrials.gov). The summary must meet EU Clinical Trials Regulation requirements for lay summaries. Approximately 200 words.
I need to explain informed consent risks to participants in a cancer immunotherapy trial. Draft an Informed Consent Form section covering the risks of cytokine release syndrome in plain language, suitable for a patient with no scientific background.
Develop a series of five social media posts (Twitter/X length) for a pharmaceutical company explaining how a new multiple sclerosis treatment works, what the clinical trial showed, and how patients can talk to their doctor about it. Ensure promotional compliance language is noted.
5. Scientific Communication and Slide Decks
Create an outline for a 15-minute medical congress presentation on the results of a head-to-head Phase III trial comparing two checkpoint inhibitors in melanoma. Suggest five to six key slides, the core message for each, and the most impactful data to display.
Write speaker notes for a slide showing a Kaplan-Meier curve demonstrating improved progression-free survival for a novel oncology drug (HR 0.62, p<0.001). Explain the curve, what the hazard ratio means, and why this result is clinically meaningful. Notes should be 150–200 words.
Draft a scientific poster abstract (250 words) for the American Heart Association annual meeting. Topic: a retrospective real-world evidence study showing that statin adherence reduces 30-day readmission rates in post-MI patients by 22%.
I need to simplify a complex pharmacokinetic data slide for a non-clinical audience (hospital formulary committee). Rewrite the following PK summary: [paste text] in plain terms, focusing on the practical dosing implications rather than the technical parameters.
Generate five potential titles for a medical education webinar aimed at primary care physicians about the updated treatment guidelines for type 2 diabetes, incorporating GLP-1 agonists and SGLT2 inhibitors as first-line options.
6. Literature Review and Evidence Synthesis
I am conducting a systematic literature review on biologics for pediatric inflammatory bowel disease. Write a PICO framework for this review and draft a Boolean search string suitable for PubMed, covering the past 10 years and limiting to RCTs and systematic reviews.
Summarize the following five abstracts on PCSK9 inhibitor cardiovascular outcomes into a comparative evidence table with columns for study design, population, intervention, primary endpoint, and key result: [paste abstracts].
Write the Background section for a health technology assessment (HTA) submission for a new oral anticoagulant for atrial fibrillation. Cover disease burden, current standard of care, unmet need, and a brief overview of the evidence landscape. Approximately 600 words.
I need to critically appraise the following RCT for inclusion in a meta-analysis: [paste abstract]. Assess the risk of bias using the Cochrane RoB 2 tool domains (randomization, deviations, missing data, measurement, selection) and provide a brief rationale for each judgment.
Generate a gap analysis comparing the current evidence base for a biosimilar adalimumab product versus the reference product. Identify which clinical data packages (PK, efficacy, immunogenicity, safety) are still needed to support a full regulatory submission.
7. Quality, Style, and Professional Development
Review the following paragraph from a clinical trial report for passive voice, nominalizations, and overly complex sentence structure: [paste paragraph]. Rewrite it to be clearer and more direct while maintaining scientific accuracy.
I need to harmonize the writing style across sections of a regulatory document written by four different authors. Provide a style guide checklist covering: preferred tense, use of abbreviations, number formatting, statistical result reporting format, and table/figure citation style.
Explain the key differences between ICH E6 (GCP) and ICH E3 (CSR structure) guidelines and why a medical writer needs to understand both when writing clinical study reports.
I am a freelance medical writer transitioning from academic research. Write a template cover letter I can customize when pitching my services to a CRO or pharmaceutical company, highlighting my publications, scientific background, and regulatory writing interest.
Generate a self-assessment questionnaire (10 questions) that a junior medical writer can use to evaluate their readiness to take on a full CSR independently, covering document structure knowledge, regulatory familiarity, data interpretation, and quality review skills.
Get All 35 Prompts in One Place
If these prompts were useful, I've compiled all 35 into a ready-to-use toolkit with bonus prompts and usage notes.
Get the complete AI Prompt Toolkit for this profession →
Works with ChatGPT, Claude, and DeepSeek.
Top comments (0)